AU2002316385A1 - Therapeutic combinations for the treatment of hormone deficiencies - Google Patents

Therapeutic combinations for the treatment of hormone deficiencies

Info

Publication number
AU2002316385A1
AU2002316385A1 AU2002316385A AU2002316385A AU2002316385A1 AU 2002316385 A1 AU2002316385 A1 AU 2002316385A1 AU 2002316385 A AU2002316385 A AU 2002316385A AU 2002316385 A AU2002316385 A AU 2002316385A AU 2002316385 A1 AU2002316385 A1 AU 2002316385A1
Authority
AU
Australia
Prior art keywords
treatment
therapeutic combinations
hormone deficiencies
hormone
deficiencies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002316385A
Inventor
Roland Gerritsen Van Der Hoop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Products LLC
Original Assignee
Solvay Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Inc filed Critical Solvay Pharmaceuticals Inc
Publication of AU2002316385A1 publication Critical patent/AU2002316385A1/en
Abandoned legal-status Critical Current

Links

AU2002316385A 2001-06-27 2002-06-26 Therapeutic combinations for the treatment of hormone deficiencies Abandoned AU2002316385A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/892,981 2001-06-27

Publications (1)

Publication Number Publication Date
AU2002316385A1 true AU2002316385A1 (en) 2003-03-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP1404343A4 (en) Therapeutic combinations for the treatment of hormone deficiencies
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2003300791A1 (en) Combination therapy for the treatment of pain
HK1073997A1 (en) Administration of agents for the treatment of inflammation
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
AU2002342613A1 (en) Treatment for wounds
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
AU2002343739A1 (en) Improved therapy for topical diseases
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2002357830A1 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2001232787A1 (en) Airway alkalinization as therapy for airway diseases
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU2002319286A1 (en) Skin treatment
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU2002304883A1 (en) Device for the treatment of tumours
AU1405001A (en) Treatment of diseases
AU2002351798A1 (en) Methods and dosage forms for improving the bioavailability of therapeutic agents
AU2002316385A1 (en) Therapeutic combinations for the treatment of hormone deficiencies
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
HUP0402664A3 (en) 2-indanylamino derivatives for the therapy of chronic pain
AU2001274446A1 (en) Vip-related peptides for the treatment of skin disorders